Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics (CRDL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,533
  • Shares Outstanding, K 63,703
  • Annual Sales, $ 60 K
  • Annual Income, $ -25,240 K
  • 60-Month Beta -0.70
  • Price/Sales 500.73
  • Price/Cash Flow N/A
  • Price/Book 0.70
Trade CRDL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.38
  • Most Recent Earnings -0.10 on 11/10/22
  • Next Earnings Date 11/21/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 809.87% ( +235.31%)
  • Historical Volatility 85.55%
  • IV Percentile 98%
  • IV Rank 70.37%
  • IV High 1,140.37% on 09/23/22
  • IV Low 24.85% on 03/16/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 6,187
  • Open Int (30-Day) 6,251

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +1,110,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4800 +7.35%
on 11/29/22
0.7113 -27.56%
on 11/15/22
-0.0707 (-12.06%)
since 10/28/22
3-Month
0.4800 +7.35%
on 11/29/22
1.3400 -61.54%
on 09/15/22
-0.6947 (-57.41%)
since 08/30/22
52-Week
0.4800 +7.35%
on 11/29/22
2.3600 -78.17%
on 01/19/22
-1.6447 (-76.14%)
since 11/26/21

Most Recent Stories

More News
Here's Why Cardiol Therapeutics Inc. (CRDL) Could be Great Choice for a Bottom Fisher

Cardiol Therapeutics Inc. (CRDL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions...

CRDL : 0.5153 (+4.10%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...

CRDL : 0.5153 (+4.10%)
CRDL.TO : 0.67 (-1.47%)
JNJ : 178.00 (+1.08%)
TAK : 14.73 (+1.59%)
NVO : 124.60 (+2.68%)
BMY : 80.28 (+1.58%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

/PRNewswire/ -- As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, the concern that it could increase...

CRDL.TO : 0.67 (-1.47%)
JNJ : 178.00 (+1.08%)
TAK : 14.73 (+1.59%)
NVO : 124.60 (+2.68%)
BMY : 80.28 (+1.58%)
CRDL : 0.5153 (+4.10%)
Air Pollution is a Global Heart and Lung Health Concern

/PRNewswire/ -- Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality...

CRDL.TO : 0.67 (-1.47%)
GSK : 34.59 (+0.67%)
AZN : 67.97 (+2.86%)
REGN : 751.70 (+2.12%)
CRDL : 0.5153 (+4.10%)
Air Pollution is a Global Heart and Lung Health Concern

Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected...

CRDL : 0.5153 (+4.10%)
CRDL.TO : 0.67 (-1.47%)
GSK : 34.59 (+0.67%)
AZN : 67.97 (+2.86%)
REGN : 751.70 (+2.12%)
The Healthcare Companies Fighting the World’s Biggest Killers

Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the...

CRDL : 0.5153 (+4.10%)
CRDL.TO : 0.67 (-1.47%)
VRNA : 12.90 (-0.08%)
PODD : 299.37 (+3.75%)
NVS : 89.56 (+2.52%)
The Healthcare Companies Fighting the World's Biggest Killers

/PRNewswire/ -- Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the healthcare sector are...

CRDL.TO : 0.67 (-1.47%)
VRNA : 12.90 (-0.08%)
PODD : 299.37 (+3.75%)
NVS : 89.56 (+2.52%)
CRDL : 0.5153 (+4.10%)
Tackling Recurring Health Conditions Offers Hope to Patients

Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...

TECK : 37.09 (+4.98%)
CRDL : 0.5153 (+4.10%)
CRDL.TO : 0.67 (-1.47%)
MRK : 110.12 (+1.18%)
TECH : 84.99 (+3.94%)
NTRA : 41.12 (+10.57%)
As Health Problems Mount Patients Welcome New Treatments

Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – There are several serious health problems facing society today. Some, like heart disease, gastrointestinal diseases, cancer,...

CRDL : 0.5153 (+4.10%)
CRDL.TO : 0.67 (-1.47%)
TAK : 14.73 (+1.59%)
ABT : 107.58 (+2.46%)
BMY : 80.28 (+1.58%)
NVO : 124.60 (+2.68%)
Breakthroughs In Treating Killer Diseases Could Lengthen Life

Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal...

CRDL : 0.5153 (+4.10%)
CRDL.TO : 0.67 (-1.47%)
GSK : 34.59 (+0.67%)
AZN : 67.97 (+2.86%)
JNJ : 178.00 (+1.08%)
LLY : 371.08 (+1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

See More

Key Turning Points

3rd Resistance Point 0.5602
2nd Resistance Point 0.5451
1st Resistance Point 0.5302
Last Price 0.5153
1st Support Level 0.5002
2nd Support Level 0.4851
3rd Support Level 0.4702

See More

52-Week High 2.3600
Fibonacci 61.8% 1.6418
Fibonacci 50% 1.4200
Fibonacci 38.2% 1.1982
Last Price 0.5153
52-Week Low 0.4800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar